5q1c
From Proteopedia
(Difference between revisions)
(One intermediate revision not shown.) | |||
Line 1: | Line 1: | ||
==Ligand binding to FARNESOID-X-RECEPTOR== | ==Ligand binding to FARNESOID-X-RECEPTOR== | ||
- | <StructureSection load='5q1c' size='340' side='right' caption='[[5q1c]], [[Resolution|resolution]] 2.30Å' scene=''> | + | <StructureSection load='5q1c' size='340' side='right'caption='[[5q1c]], [[Resolution|resolution]] 2.30Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5q1c]] is a 4 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5q1c]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5Q1C OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5Q1C FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=9NA:(2S)-2-cyclohexyl-2-[2-(2,6-dimethoxypyridin-3-yl)-5,6-difluoro-1H-benzimidazol-1-yl]-N-(trans-4-hydroxycyclohexyl)acetamide'>9NA</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=9NA:(2S)-2-cyclohexyl-2-[2-(2,6-dimethoxypyridin-3-yl)-5,6-difluoro-1H-benzimidazol-1-yl]-N-(trans-4-hydroxycyclohexyl)acetamide'>9NA</scene></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5q1c FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5q1c OCA], [https://pdbe.org/5q1c PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5q1c RCSB], [https://www.ebi.ac.uk/pdbsum/5q1c PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5q1c ProSAT]</span></td></tr> |
</table> | </table> | ||
+ | == Disease == | ||
+ | [https://www.uniprot.org/uniprot/NCOA1_HUMAN NCOA1_HUMAN] Note=A chromosomal aberration involving NCOA1 is a cause of rhabdomyosarcoma. Translocation t(2;2)(q35;p23) with PAX3 generates the NCOA1-PAX3 oncogene consisting of the N-terminus part of PAX3 and the C-terminus part of NCOA1. The fusion protein acts as a transcriptional activator. Rhabdomyosarcoma is the most common soft tissue carcinoma in childhood, representing 5-8% of all malignancies in children. | ||
== Function == | == Function == | ||
- | [ | + | [https://www.uniprot.org/uniprot/NCOA1_HUMAN NCOA1_HUMAN] Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Involved in the coactivation of different nuclear receptors, such as for steroids (PGR, GR and ER), retinoids (RXRs), thyroid hormone (TRs) and prostanoids (PPARs). Also involved in coactivation mediated by STAT3, STAT5A, STAT5B and STAT6 transcription factors. Displays histone acetyltransferase activity toward H3 and H4; the relevance of such activity remains however unclear. Plays a central role in creating multisubunit coactivator complexes that act via remodeling of chromatin, and possibly acts by participating in both chromatin remodeling and recruitment of general transcription factors. Required with NCOA2 to control energy balance between white and brown adipose tissues. Required for mediating steroid hormone response. Isoform 2 has a higher thyroid hormone-dependent transactivation activity than isoform 1 and isoform 3.<ref>PMID:9427757</ref> <ref>PMID:7481822</ref> <ref>PMID:9223431</ref> <ref>PMID:9296499</ref> <ref>PMID:9223281</ref> <ref>PMID:10449719</ref> <ref>PMID:12954634</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 19: | Line 21: | ||
</div> | </div> | ||
<div class="pdbe-citations 5q1c" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5q1c" style="background-color:#fffaf0;"></div> | ||
+ | |||
+ | ==See Also== | ||
+ | *[[Bile acid receptor 3D structures|Bile acid receptor 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: | + | [[Category: Homo sapiens]] |
- | [[Category: Benz | + | [[Category: Large Structures]] |
- | [[Category: Burger | + | [[Category: Benz J]] |
- | [[Category: Burley | + | [[Category: Burger D]] |
- | [[Category: Joseph | + | [[Category: Burley SK]] |
- | [[Category: Kuhn | + | [[Category: Joseph C]] |
- | [[Category: Rudolph | + | [[Category: Kuhn B]] |
- | [[Category: Ruf | + | [[Category: Rudolph MG]] |
- | [[Category: Shao | + | [[Category: Ruf A]] |
- | [[Category: Thoma | + | [[Category: Shao C]] |
- | [[Category: Yang | + | [[Category: Thoma R]] |
- | + | [[Category: Yang H]] | |
- | + | ||
- | + | ||
- | + |
Current revision
Ligand binding to FARNESOID-X-RECEPTOR
|
Categories: Homo sapiens | Large Structures | Benz J | Burger D | Burley SK | Joseph C | Kuhn B | Rudolph MG | Ruf A | Shao C | Thoma R | Yang H